Hangzhou Tigermed Consulting Co., Ltd.
Status: Publicly traded
Direct answer
Hangzhou Tigermed Consulting Co., Ltd. is publicly traded on HKSE under the ticker 3347.HK.
Hangzhou Tigermed Consulting Co., Ltd. operates as a contract research organization (CRO) across the People's Republic of China and globally, offering an extensive suite of services. The company's operations are divided into two primary segments: Clinical Trial Solutions and Clinical-related and Laboratory Services. Its service portfolio includes support for regulatory submissions and approvals, medical translation,...
Can you invest in Hangzhou Tigermed Consulting Co., Ltd.?
Yes. Hangzhou Tigermed Consulting Co., Ltd. is publicly traded on HKSE under the ticker 3347.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Hangzhou Tigermed Consulting Co., Ltd.
Detailed equity research is provided by MarketSnap.